In 2016, Xinhong Medical's revenue was 450 million yuan: net profit of 24.7 million yuan
On April 17th, the 2016 annual report released by Xinhong Medical showed that the operating income in 2016 was 448 million yuan, up 65.93% over the same period of last year; the net profit attributable to the listed company shareholders was 2469. 640,000 yuan, an increase of 113.64% over the same period of last year; basic earnings per share was 0.73 yuan, compared with 0.39 yuan in the same period last year. As of 2016, Xinhong's medical assets totaled 355 million yuan, an increase of 72.09% from the end of the previous year; the asset-liability ratio was 66.68%, down 6.07 percentage points from the end of the previous year's 72.75%. . The net cash flow from operating activities was RMB 15.8572 million in the current period, compared with RMB 183.331 million in the same period last year. During the reporting period, Xinhong Medical's operating income increased by 65.93% compared with the same period of last year, mainly because the operating income of the parent company increased from 225 million yuan in the previous year to 303 million yuan, an increase of 34.67%. The subsidiary Tianjin Hongxin Ruikang Medical Technology Co., Ltd. increased from 0.40 billion yuan in the previous year to 105 million yuan, an increase of 162.50%. The subsidiary Tianjin Dingxin Medical Technology Co., Ltd. was 0 from the previous year. 19.19 billion yuan increased to 0.58 billion yuan, an increase of 205.26%. During the reporting period, Xinhong Medical's non-operating income increased by 193.87% compared with the same period of last year, mainly due to the receipt of subsidies from the Municipal Finance Bureau and the Dongli District Government in 2016, and received the relevant subsidies for the listing of the New Third Board this year. 2.5 million yuan, government departments rewarded 934,200 yuan. According to the data of the Dibei New Third Board Research Institute, the main business of Xinhong Medical is to provide in-vitro diagnostic products and professional technical support services to various medical laboratories (mainly hospitals). Some important matters during the reporting period: Shanghai J.Shine Co.,Ltd , https://www.jshinechem.com